Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Alpaslan Tasdogan

Department of Dermatology, University Hospital Essen and German Cancer Consortium, Partner Site, Essen, Germany
Publications

New Methods for Studying Cancer Metastases Using Metabolomics

90% of cancer patients’ deaths are the result of metastasis. The lack of reliable and sensitive tools to record metabolic processes in metastatic cancer cells has hampered our understanding of the involvement of metabolism during this process. We go over the current research methodologies for investigating I cancer cell metabolism in primary ... Read More»

Alpaslan Tasdogan

: J Cell Mol Pharmacol 2022,6,131

10.4172/jcmp.1000131

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics
Top